Pediatrik Hematolojik ve Onkolojik Aciller

Acıpayam C, Kandemir Gülmez T, Parlar M, Özen O.N, Ekici S, Örenler M. Olgularla Hematolojik ve Onkolojik Aciller. KSU Medical Journal 2019;14(1): 31-36.

Stephanos K, Dubbs SB. Pediatric Hematologic and Oncologic Emergencies. Emerg Med Clin North Am. 2021 Aug;39(3):555-571.

Payne AB, Mehal JM, Chapman C, Haberling DL, Richardson LC, Bean CJ, Hooper WC. Trends in Sickle Cell Disease-Related Mortality in the United States, 1979 to 2017. Ann Emerg Med. 2020 Sep;76(3S):S28-S36.

Elmariah H, Garrett ME, De Castro LM, et al. Factors associated with survival in a contemporary adult sickle cell disease cohort. Am J Hematol 2014;89(5):530–5.

Gaston MH, Verter JI, Woods G, et al. Prophylaxis with oral penicillin in children with sickle cell anemia. A randomized trial. N Engl J Med 1986;314(25):1593–9.

Brandow AM, Carroll CP, Creary S, et al. American Society of Hematology 2020 guidelines for sickle cell disease: management of acute and chronic pain. Blood Adv 2020;4(12):2656–701.

Şenol S. Hemofili Tanılı Çocukta Tedavinin Uygulanması ve Bakım İlkeleri. Şenol S, (yazar). Kanama Hastalığı Olan Çocuğa Yaklaşım Özel Sayısı, Ankara: Türkiye Klinikleri, 2016:8-14.

Michel M. Immune thrombocytopenia nomenclature, consensus reports, and guidelines: what are the consequences for daily practice and clinical research? Semin Hematol 2013;50(Suppl 1):S50–4.

Neunert C, Noroozi N, Norman G, et al. Severe bleeding events in adults and children with primary immune thrombocytopenia: a systematic review. J Thromb Haemost 2015;13(3):457–64.

Neunert C, Terrell DR, Arnold DM, et al. American Society of Hematology 2019 guidelines for immune thrombocytopenia. Blood Adv 2019;3(23):3829–66.

Leung KKY, Hon KL, Hui WF, Leung AK, Li CK. Therapeutics for paediatric oncological emergencies. Drugs Context. 2021 Jun 23;10:2020-11-5.

Çiftçi A.Ç , Küpeli S. Pediatrik Onkolojide Tıbbi Acillerin Yönetimi. Archives Medical Review Journal. 2016; 25(3):369-405.

Adeyinka A, Bashir K. Tumor lysis syndrome. In: StatPearls [Internet]. Treasure Island, FL: StatPearls Publishing; 2020.

Abu-Alfa AK, Younes A. Tumor lysis syndrome and acute kidney injury: evaluation, prevention, and management. Am J Kidney Dis. 2010 May;55(5 Suppl 3):S1-13; quiz S14-9.

Beker B, Berrak S.G. Hematolojik Aciller. Anak S.S, Aydoğan G, Çetin M, İrken G, Kemahlı S, Öztürk G, Yeşilkipek M.A (yazarlar). Pediatrik Hematoloji, İstanbul: İstanbul Medikal Yayıncılık, 2011: 791-799.

Celkan T. Çocukluk Çağında Hematolojik Malignitelerin Tedavisinde Aciller ve Güncel Yaklaşımlar. Türkiye Klinikleri J Pediatr Sci 2009;5(1):104-14

Halfdanarson TR, Hogan WJ, Madsen BE. Emergencies in Hematology and Oncology. Mayo Clin Proc. 2017 Apr;92(4):609-641.

Boyce AM. Denosumab: an Emerging Therapy in Pediatric Bone Disorders. Curr Osteoporos Rep. 2017 Aug;15(4):283-292.

Freedman J.L, Elgarten C.W, Rheingold S.R. Management of oncologic emergencies. JD Fish, JM Lipton, P Lanzkowsky, editors. Lanzkowsky's manual of pediatric hematology and oncology. Seventh edition. USA: Elsevier Inc;2022.p.658-674.

Padidela R, Fiest M, Arya V, et al. Insulinoma in childhood: clinical, radiological, molecular and histological aspects of nine patients. Eur J Endocrinol. 2014 Apr 10;170(5):741-7.

Ganzel C, Becker J, Mintz PD, Lazarus HM, Rowe JM. Hyperleukocytosis, leukostasis and leukapheresis: practice management. Blood Rev. 2012;26(3):117–122.

Jain R, Bansal D, Marwaha RK. Hyperleukocytosis: emergency management. Indian J Pediatr. 2013;80(2):144–148.

Inaba H, Fan Y, Pounds S, et al. Clinical and biologic features and treatment outcome of children with newly diagnosed acute myeloid leukemia and hyperleukocytosis. Cancer. 2008;113(3):522–529.

Erdem F, Yusuf B. Hiperviskozite. Okutan H (yazar). Hematolojik Aciller Özel Sayısı, Ankara: Türkiye Klinikleri, 2016: 31-35.

Kongstad C, Mikkelsen TS, Hvas A-M. Disseminated intravascular coagulation in children with cancer: a systematic review. Pediatr Hematol Oncol. 2020;37(5):390–411.

Mann G, Reinhardt D, Ritter J, et al. Treatment with all-trans retinoic acid in acute promyelocytic leukemia reduces early deaths in children. Ann Hematol. 2001;80(7):417–422.

Acıpayam C, Kandemir Gülmez T, Parlar M, Özen O.N, Ekici S, Örenler M. Olgularla Hematolojik ve Onkolojik Aciller. KSU Medical Journal 2019;14(1): 31-36.

Stephanos K, Dubbs SB. Pediatric Hematologic and Oncologic Emergencies. Emerg Med Clin North Am. 2021 Aug;39(3):555-571.

Payne AB, Mehal JM, Chapman C, Haberling DL, Richardson LC, Bean CJ, Hooper WC. Trends in Sickle Cell Disease-Related Mortality in the United States, 1979 to 2017. Ann Emerg Med. 2020 Sep;76(3S):S28-S36.

Elmariah H, Garrett ME, De Castro LM, et al. Factors associated with survival in a contemporary adult sickle cell disease cohort. Am J Hematol 2014;89(5):530–5.

Gaston MH, Verter JI, Woods G, et al. Prophylaxis with oral penicillin in children with sickle cell anemia. A randomized trial. N Engl J Med 1986;314(25):1593–9.

Brandow AM, Carroll CP, Creary S, et al. American Society of Hematology 2020 guidelines for sickle cell disease: management of acute and chronic pain. Blood Adv 2020;4(12):2656–701.

Şenol S. Hemofili Tanılı Çocukta Tedavinin Uygulanması ve Bakım İlkeleri. Şenol S, (yazar). Kanama Hastalığı Olan Çocuğa Yaklaşım Özel Sayısı, Ankara: Türkiye Klinikleri, 2016:8-14.

Michel M. Immune thrombocytopenia nomenclature, consensus reports, and guidelines: what are the consequences for daily practice and clinical research? Semin Hematol 2013;50(Suppl 1):S50–4.

Neunert C, Noroozi N, Norman G, et al. Severe bleeding events in adults and children with primary immune thrombocytopenia: a systematic review. J Thromb Haemost 2015;13(3):457–64.

Neunert C, Terrell DR, Arnold DM, et al. American Society of Hematology 2019 guidelines for immune thrombocytopenia. Blood Adv 2019;3(23):3829–66.

Leung KKY, Hon KL, Hui WF, Leung AK, Li CK. Therapeutics for paediatric oncological emergencies. Drugs Context. 2021 Jun 23;10:2020-11-5.

Çiftçi A.Ç , Küpeli S. Pediatrik Onkolojide Tıbbi Acillerin Yönetimi. Archives Medical Review Journal. 2016; 25(3):369-405.

Adeyinka A, Bashir K. Tumor lysis syndrome. In: StatPearls [Internet]. Treasure Island, FL: StatPearls Publishing; 2020.

Abu-Alfa AK, Younes A. Tumor lysis syndrome and acute kidney injury: evaluation, prevention, and management. Am J Kidney Dis. 2010 May;55(5 Suppl 3):S1-13; quiz S14-9.

Beker B, Berrak S.G. Hematolojik Aciller. Anak S.S, Aydoğan G, Çetin M, İrken G, Kemahlı S, Öztürk G, Yeşilkipek M.A (yazarlar). Pediatrik Hematoloji, İstanbul: İstanbul Medikal Yayıncılık, 2011: 791-799.

Celkan T. Çocukluk Çağında Hematolojik Malignitelerin Tedavisinde Aciller ve Güncel Yaklaşımlar. Türkiye Klinikleri J Pediatr Sci 2009;5(1):104-14

Halfdanarson TR, Hogan WJ, Madsen BE. Emergencies in Hematology and Oncology. Mayo Clin Proc. 2017 Apr;92(4):609-641.

Boyce AM. Denosumab: an Emerging Therapy in Pediatric Bone Disorders. Curr Osteoporos Rep. 2017 Aug;15(4):283-292.

Freedman J.L, Elgarten C.W, Rheingold S.R. Management of oncologic emergencies. JD Fish, JM Lipton, P Lanzkowsky, editors. Lanzkowsky's manual of pediatric hematology and oncology. Seventh edition. USA: Elsevier Inc;2022.p.658-674.

Padidela R, Fiest M, Arya V, et al. Insulinoma in childhood: clinical, radiological, molecular and histological aspects of nine patients. Eur J Endocrinol. 2014 Apr 10;170(5):741-7.

Ganzel C, Becker J, Mintz PD, Lazarus HM, Rowe JM. Hyperleukocytosis, leukostasis and leukapheresis: practice management. Blood Rev. 2012;26(3):117–122.

Jain R, Bansal D, Marwaha RK. Hyperleukocytosis: emergency management. Indian J Pediatr. 2013;80(2):144–148.

Inaba H, Fan Y, Pounds S, et al. Clinical and biologic features and treatment outcome of children with newly diagnosed acute myeloid leukemia and hyperleukocytosis. Cancer. 2008;113(3):522–529.

Erdem F, Yusuf B. Hiperviskozite. Okutan H (yazar). Hematolojik Aciller Özel Sayısı, Ankara: Türkiye Klinikleri, 2016: 31-35.

Kongstad C, Mikkelsen TS, Hvas A-M. Disseminated intravascular coagulation in children with cancer: a systematic review. Pediatr Hematol Oncol. 2020;37(5):390–411.

Mann G, Reinhardt D, Ritter J, et al. Treatment with all-trans retinoic acid in acute promyelocytic leukemia reduces early deaths in children. Ann Hematol. 2001;80(7):417–422.